CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results
Go back to CytomX Therapeutics to Announce Fourth Quarter 2019 Financial Results| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.72 +0.05 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.67 | 52 Week High | $24.68 | |||
| Open | $3.72 | 52 Week Low | $9.10 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.69 | EPS | $0.00 | |||
| Volume | 6,497,314 | |||||
